BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18950300)

  • 1. Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy.
    Mangiavacchi M; Gasparini M; Genovese S; Pini D; Klersy C; Bragato R; Andreuzzi B; Municinò A; Regoli F; Galimberti P; Ceriotti C; Gronda E
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1425-32. PubMed ID: 18950300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-minute walking test predicts long-term cardiac death in patients who received cardiac resynchronization therapy.
    Castel MA; Méndez F; Tamborero D; Mont L; Magnani S; Tolosana JM; Berruezo A; Godoy M; Sitges M; Vidal B; Roig E; Brugada J
    Europace; 2009 Mar; 11(3):338-42. PubMed ID: 19136491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry.
    Gasparini M; Lunati M; Santini M; Tritto M; Curnis A; Bocchiardo M; Vincenti A; Pistis G; Valsecchi S; Denaro A;
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S2-10. PubMed ID: 17169128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.
    Smooke S; Horwich TB; Fonarow GC
    Am Heart J; 2005 Jan; 149(1):168-74. PubMed ID: 15660049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors.
    Bai R; Di Biase L; Elayi C; Ching CK; Barrett C; Philipps K; Lim P; Patel D; Callahan T; Martin DO; Arruda M; Schweikert RA; Saliba WI; Wilkoff B; Natale A
    J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1259-65. PubMed ID: 18631272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population.
    Foley PW; Chalil S; Khadjooi K; Smith RE; Frenneaux MP; Leyva F
    Europace; 2008 Nov; 10(11):1302-7. PubMed ID: 18827063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
    Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F
    Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.
    Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R
    Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cardiac resynchronization therapy in very old patients: the Insync/Insync ICD Italian Registry.
    Achilli A; Turreni F; Gasparini M; Lunati M; Sassara M; Santini M; Landolina M; Padeletti L; Puglisi A; Bocchiardo M; Orazi S; Perego GB; Valsecchi S; Denaro A
    Europace; 2007 Sep; 9(9):732-8. PubMed ID: 17636304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery.
    Mohammadi S; Dagenais F; Mathieu P; Kingma JG; Doyle D; Lopez S; Baillot R; Perron J; Charbonneau E; Dumont E; Metras J; Desaulniers D; Voisine P
    Circulation; 2007 Sep; 116(11 Suppl):I220-5. PubMed ID: 17846307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus and long-term outcome in heart failure patients after surgical ventricular restoration.
    Castelvecchio S; Ranucci M; Di Donato M; Menicanti L
    Ann Thorac Surg; 2009 Nov; 88(5):1451-6. PubMed ID: 19853091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
    Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Lamas GA
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1160-6. PubMed ID: 18554201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
    Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F
    Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy.
    Shalaby A; El-Saed A; Voigt A; Albany C; Saba S
    Pacing Clin Electrophysiol; 2008 May; 31(5):575-9. PubMed ID: 18439171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronization therapy in patients with mildly impaired left ventricular function.
    Foley PW; Stegemann B; Smith RE; Sanderson JE; Leyva F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S186-9. PubMed ID: 19250090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cardiac resynchronisation therapy on adaptation of circulatory and respiratory systems to exercise assessed by cardiopulmonary exercise test in patients with chronic heart failure.
    Chwyczko T; Sterliński M; Maciag A; Firek B; Labecka A; Jankowska A; Kośmicki M; Kowalik I; Malczewska B; Szwed H
    Kardiol Pol; 2008 Apr; 66(4):406-12; discussion 413-4. PubMed ID: 18473269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.
    Anand IS; Carson P; Galle E; Song R; Boehmer J; Ghali JK; Jaski B; Lindenfeld J; O'Connor C; Steinberg JS; Leigh J; Yong P; Kosorok MR; Feldman AM; DeMets D; Bristow MR
    Circulation; 2009 Feb; 119(7):969-77. PubMed ID: 19204305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.